乙型肝炎病毒标志物阳性肺结核患者肝功能变化的观察  

Markers of hepatitis B virus - positive tuberculosis patients observed changes in liver function

作　　者：戎华[1] 

机构地区：[1]吉林省结核病医院,130500

出　　处：《医学信息（下旬刊）》2009年第11期92-92,共1页Medical information

摘　　要：笔者总结了自2000年1月～2008年11月来我院治疗的肺结核病例中，元症状乙型肝炎病毒标志物携带者共176例。占出院病人总数的22．1％，为探讨抗痨药物对这类患者肝功能的影响，我们寻找合理安全用药，尽量减少或避免抗结核药物治疗的中断或失败。对176例HBVM阳性肺结核患者在住院化疗中进行了肝功能变化的观察。鉴于我国是乙肝的高发地区，无症状HBVM携带者占全国总人口的10％-20％。因此。必须在化疗前发现这类病例，以便选择最佳化疗方案，减少药物性肝炎的发生。The paper summarizes Since January 2000 - November 2008 to my hospital for treatment of tuberculosis cases, asymptomatic carriers of hepatitis B virus markers in a total of 176 eases, accounting for 22.1% of the total number of discharged patients, in order to explore the anti - tuberculosis drugs liver function in patients with this type of impact, we find reasonable and safe medication to minimize or avoid the anti - TB drug treatment interruption or failure. HBVM of 176 patients with chemotherapy - positive tuberculosis patients in the hospital carried out observation of changes in liver function. In view of China is a high incidence of hepatitis B, asymptomatie carriers HBVM the eountry＇s total population, accounted for 10% - 20%. Therefore, before chemotherapy was found to be in such cases, In order to select the best regimen to reduce the incidence of drug -induced hepatitis.

关 键 词：乙型肝炎病毒标志物 肺结核 肝功能 

分 类 号：R521[医药卫生—内科学]